Integrating Post-Radiotherapy Plasma EBV DNA and TNM Stage for Risk Stratification of Nasopharyngeal Carcinoma to Adjuvant Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Integrating Post-Radiotherapy Plasma Epstein-Barr Virus DNA and TNM Stage for Risk Stratification of Nasopharyngeal Carcinoma to Adjuvant Therapy
Ann. Oncol 2020 Mar 23;[EPub Ahead of Print], EP Hui, WF Li, BB Ma, WKJ Lam, KCA Chan, F Mo, QH Ai, AD King, CH Wong, R Guo, DMC Poon, M Tong, L Li, TKH Lau, KCW Wong, DCM Lam, YMD Lo, J Ma, ATC ChanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.